
Pharma Pulse 3/14/24: Celebrity Endorsements in Ozempic, Enhancing Transparency Between Patients and Researchers & more
The latest news for pharma industry insiders.
In this Applied Clinical Trials video interview, Julia Lakeland, Chief Product Officer, uMotif, discusses the development of new technologies helping to foster trust and informed decision-making throughout the clinical trial process.
This podcast episode discussed the impact of celebrity endorsements on trends in weight loss drugs like Ozempic, body image issues, and the role of pharmacists in educating patients on appropriate use of GLP-1 medications for weight management and chronic diseases.
Companies like OpenAI and Midjourney build chatbots, image generators and other artificial intelligence tools that operate in the digital world. Now, a start-up founded by three former OpenAI researchers is using the technology development methods behind chatbots to build A.I. technology that can navigate the physical world.
DirectMed Imaging announced the acquisition of Houston-based Titanium Medical Imaging, a company with vast expertise in Canon/Toshiba medical parts and systems.
Very good discussion from leaders at Hackensack Meridian Health about cybersecurity. A key takeaway: health systems must constantly learn and evolve. "If you're standing still in cyber, you're left behind." #HIMSS24
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.